Navigation Links
DelMar Pharmaceuticals to Present Interim Clinical Data for VAL-083 in Glioblastoma at Society of Neuro-Oncology
Date:11/14/2013

VANCOUVER, British Columbia and MENLO PARK, Calif., Nov. 14, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced that the Company will present interim clinical trial data for VAL-083 in glioblastoma at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO) being held in conjunction with the 18th Annual Society for Neuro-Oncology (SNO) meeting. The WFNO/SNO meeting will take place November 21st through 24th in San Francisco.  Glioblastoma is the most common and aggressive form of brain cancer, and new therapies are greatly needed.

DelMar will present the poster entitled, "Phase I/II study of VAL-083 in patients with recurrent malignant glioma or progressive-secondary brain tumor," from 7 pm to 9 pm on Friday, November 22nd. The abstract, number MR-028, is now published in the Journal of Neuro-Oncology and can also be found by clicking here.

About VAL-083
VAL-083 represents a first-in-class, small-molecule chemotherapeutic with a unique mechanism of action. In more than 40 Phase 1 and 2 clinical studies sponsored by the National Cancer Institute (NCI), VAL-083 has shown safety and efficacy in treating a number of cancers including lung, brain, cervical, ovarian tumors and leukemia. VAL-083 is approved in China for the treatment of chronic myelogenous leukemia and lung cancer and has received orphan drug designation in Europe and the U.S. for the treatment of gliomas.  As a potential treatment for glioblastoma, VAL-083's mechanism of action is unaffected by the expression of MGMT
'/>"/>

SOURCE DelMar Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
2. DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement
3. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
4. DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
5. DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant
6. DelMar Pharmaceuticals to Present at the 25th Annual ROTH Capital Partners Growth Stock Conference
7. DelMar Pharma Named to Rocket Builders 2013"Ready to Rocket" List
8. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
9. DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083
10. DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
11. DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... , Sept. 4, 2015  Allergan plc (NYSE: AGN ... Brent Saunders , CEO and President of Allergan, will provide ... Morgan Stanley Global Healthcare Conference 2015 in New ... The presentation will take place on ... the Grand Hyatt New York, 109 East 42nd Street, ...
(Date:9/4/2015)... 2015  IGI Laboratories, Inc. (NYSE MKT: IG), a ... pharmaceutical company, today announced it has submitted its seventh ... and Drug Administration (FDA) of 2015, which brings the ... the FDA to twenty-nine. Jason Grenfell-Gardner ... believe our current pipeline of twenty-nine submissions, exclusive of ...
(Date:9/4/2015)... 2015 Research and ... of the "Veterinary Pharmaceutical Submissions in the ... conference to their offering. This practical ... the constituent parts of the application for marketing ... a marketing authorisation is sought in the European ...
Breaking Medicine Technology:Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 3IGI Laboratories, Inc. Announces Seventh ANDA Submission Of 2015 2Veterinary Pharmaceutical Submissions in the EU: Two day Course - London, UK - December 7-8, 2015 2
... Phase III Results -, LAUSANNE, Switzerland, ... independent biopharmaceutical development specialist,focusing on serious medical ... 9th International Symposium on GnRH in Berlin, ... with its new 6-month formulation of,Decapeptyl(R)/Trelstar(R) (triptorelin), ...
... Phosphagenics,Limited ("Phosphagenics") (ASX: POH; AIM: PSG; OTCQX: PPGNY) ... phase 2 human clinical,trial to establish the efficacy ... syndrome is advancing at three sites in Adelaide,Australia., ... participants, the,double-blind phase 2 trial, which is fully ...
Cached Medicine Technology:Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer 2Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer 3Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial 2Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial 3Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial 4
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... According to ... been developed that changes color when subjected to an impact force that is great ... be implemented in helmets or other sporting equipment so that coaches or officials would ...
(Date:9/4/2015)... ... September 04, 2015 , ... According to an article published August ... Association presented data showing that it is safe for pregnant women to undergo local ... had undergone local anesthesia with a group that hadn’t, researchers were able to determine ...
(Date:9/4/2015)... ... September 04, 2015 , ... On ... has effectively doubled the size of its annual health tech innovation program. Now ... digital health startups to compete for cash and prizes to advance their technologies ...
(Date:9/4/2015)... , ... September 04, 2015 , ... With TransCel from ... mouse all within Final Cut Pro X. With TransCel users have full control over ... width, background color, speed method, frame color, inner color, text, and more. With TransCel ...
(Date:9/4/2015)... ... 2015 , ... Mile High Connects today releases “First and Last Mile Connections,” ... sidewalks, bike paths, and other vital supports severely limit access to public transportation for ... dollars to expand public transit, there’s very little support for safe and convenient access ...
Breaking Medicine News(10 mins):Health News:New Article on Head Injury Detection Technology Highlights Implications for Head Injury Detection in Sports, says The Law Offices of Burg & Brock 2Health News:Recent Study on Dental Care During Pregnancy Demonstrates How Preventative Dental Care Really is for Everyone, Says Medical Center Dental Care 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 3Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:Missed Connections in Metro Denver Transit 2
... new study from the University of New Hampshire finds that ... abuse than has been previously recognized, with nearly half experiencing ... experience far more violence, abuse and crime than do adults," ... Research Center and the study director. "If life were this ...
... The California Center for Cardiothoracic Surgery have performed countless ... throughout Southern California. The diagnosis of lung cancer can be ... responsible for more deaths than any other type of cancer, ... a patient to return to health, a number of different ...
... ANGELES, Oct. 6 The Renaissance Laser and Vein Institute offers ... stretch marks and sagging skin like never before. Thanks to recent ... skin care lasers in the dermatological and cosmetic skin care world. ... is the Titan Procedure . The Titan laser ...
... the health care debate continues in the U.S., there,s one ... number of our professional organizations have testified about proposed health ... table as equal participants," said T. Heather Herdman, PhD, RN, ... are the largest group of health care providers in the ...
... CAMBRIDGE, Mass., Oct. 6 Panel Intelligence, LLC, is ... research. For 10 years, Panel Intelligence has provided ... from clinicians and other healthcare professionals. Panel ... populations in oncology. This research service provides cancer therapeutics ...
... Oct. 6 The 24-hour Survivor Crop Scrapbooking Marathon is ... through Susan G. Komen for the Cure, San Diego. Attendees ... to 8:00 a.m. on October 18. Sponsored by North County-based ... Quantum Learning Network (QLN) Campus. The day begins at Ever ...
Cached Medicine News:Health News:New study finds high rates of childhood exposure to violence and abuse in US 2Health News:The California Center for Cardiothoracic Surgery (heart411.com) Surgeons are Leaders in Lung Cancer Surgery 2Health News:Southern California Renaissance Laser and Vein Institute (laserandveinclinic.com) Offers Cutting Edge New Titan Procedure 2Health News:Nurses Should Be Included In Health Care Debate 2Health News:Panel Intelligence Develops Extensive Access to Patient Populations in Oncology 2Health News:Annual Scrapbooking Event in Oceanside October 17 and 18 to Benefit Susan G. Komen for the Cure 2Health News:Annual Scrapbooking Event in Oceanside October 17 and 18 to Benefit Susan G. Komen for the Cure 3
... to store valuable samples down the hall ... or under your lab bench! Highly efficient ... traditional urethane insulation, maximizes storage capacity. Holds ... accumulator increases compressor efficiency to lower power ...
... CO2 incubator with microprocessor-controlled 6-sided heating. ... door, HEPA filtered CO2 inlet and ... Simple, large character temperature and % ... and mulitple temperature monitors ensure consistent ...
IR Autoflow Dual Chamber Over-Under Water-Jacketed CO2 Incubator...
ArcticTemp Upright Freezer -20C. Quick, even freezing. Heavy duty compressor. Deep door racks. Front gated bottom shelf. Interior light. Locks One year warranty on unit and 5 year warranty on compres...
Medicine Products: